Raphaël Serreau

Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis

D. Hubert, Hélène Réglier‐Poupet, Isabelle Sermet‐Gaudelus et al. · Journal of Cystic Fibrosis · 2013 · 127 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +10

Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy

C Lebaudy, Zahir Amoura, N. Costedoat‐Chalumeau et al. · Clinical Pharmacology & Therapeutics · 2008 · 115 citations

Medicine, Pharmacokinetics, Pharmacology +15

Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction

Jeanne Sibiude, Jean Guibourdenche, Marie-Danielle Dionne et al. · PLoS ONE · 2012 · 78 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases

Raphaël Serreau, Dominique Luton, Marie‐Alice Macher et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2005 · 73 citations

Pharmacy, Obstetrics, Toxicology +17

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial

Manfred Ballmann, D. Hubert, B.M. Assael et al. · The Lancet Diabetes & Endocrinology · 2017 · 68 citations

Medicine, Endocrinology, Internal Medicine +9